🇺🇸 FDA
Patent

US 10716843

Immune enhancing recombinant dengue protein

granted A61KA61K2039/5252A61K2039/53

Quick answer

US patent 10716843 (Immune enhancing recombinant dengue protein) held by United States of America as represented by the Secretary of the Air Force expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/5252, A61K2039/53, A61K2039/545, A61K2039/55516